Association of Albumin Levels With Outcome in Intravenous Immunoglobulin–Treated Guillain-Barré Syndrome-Reference-Cited by-同舟云学术

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin–Treated Guillain-Barré Syndrome

Published:2017-02-01 Issue:2 Volume:74 Page:189
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Fokkink Willem-Jan R.¹,Walgaard Christa²,Kuitwaard Krista³,Tio-Gillen Anne P.¹,van Doorn Pieter A.²,Jacobs Bart C.¹

Affiliation:

1. Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands2Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

2. Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

3. Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands3Department of Neurology, Albert Schweitzer Hospital, Dordrecht, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a predictive model for prolonged length of stay in elderly type 2 diabetes mellitus patients combined with cerebral infarction;Frontiers in Neurology;2024-08-01

2. Efgartigimod in the treatment of Guillain–Barré syndrome;Journal of Neurology;2024-03-26

3. Serum Albumin Level Can Predict Immunotherapy Response of Neuromyelitis Optica Spectrum Disorders in the Acute Phase;Journal of Inflammation Research;2024-02

4. Factors Associated with Respiratory Insufficiency in Children with Guillain–Barré Syndrome;Neuropediatrics;2024-01-22

5. Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome;Expert Review of Neurotherapeutics;2023-10-30